184 related articles for article (PubMed ID: 26449834)
1. PET Imaging of Copper Trafficking in a Mouse Model of Alzheimer Disease.
Torres JB; Andreozzi EM; Dunn JT; Siddique M; Szanda I; Howlett DR; Sunassee K; Blower PJ
J Nucl Med; 2016 Jan; 57(1):109-14. PubMed ID: 26449834
[TBL] [Abstract][Full Text] [Related]
2. Studies of copper trafficking in a mouse model of Alzheimer's disease by positron emission tomography: comparison of
Andreozzi EM; Torres JB; Sunassee K; Dunn J; Walker-Samuel S; Szanda I; Blower PJ
Metallomics; 2017 Nov; 9(11):1622-1633. PubMed ID: 29063080
[TBL] [Abstract][Full Text] [Related]
3. Imaging of changes in copper trafficking and redistribution in a mouse model of Niemann-Pick C disease using positron emission tomography.
Baguña Torres J; Yu Z; Bordoloi J; Sunassee K; Smith D; Smith C; Chen O; Purchase R; Tuschl K; Spencer J; Platt F; Blower PJ
Biometals; 2019 Apr; 32(2):293-306. PubMed ID: 30847690
[TBL] [Abstract][Full Text] [Related]
4. Preclinical and clinical study on [
Xu M; Guo J; Gu J; Zhang L; Liu Z; Ding L; Fu H; Ma Y; Liang S; Wang H
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):652-663. PubMed ID: 34292345
[TBL] [Abstract][Full Text] [Related]
5. PET imaging analysis with 64Cu in disulfiram treatment for aberrant copper biodistribution in Menkes disease mouse model.
Nomura S; Nozaki S; Hamazaki T; Takeda T; Ninomiya E; Kudo S; Hayashinaka E; Wada Y; Hiroki T; Fujisawa C; Kodama H; Shintaku H; Watanabe Y
J Nucl Med; 2014 May; 55(5):845-51. PubMed ID: 24627433
[TBL] [Abstract][Full Text] [Related]
6. Bis(thiosemicarbazonato) Cu-64 complexes for positron emission tomography imaging of Alzheimer's disease.
Fodero-Tavoletti MT; Villemagne VL; Paterson BM; White AR; Li QX; Camakaris J; O'Keefe G; Cappai R; Barnham KJ; Donnelly PS
J Alzheimers Dis; 2010; 20(1):49-55. PubMed ID: 20164590
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
Snellman A; López-Picón FR; Rokka J; Salmona M; Forloni G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
J Nucl Med; 2013 Aug; 54(8):1434-41. PubMed ID: 23833271
[TBL] [Abstract][Full Text] [Related]
8. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.
Toyama H; Ye D; Ichise M; Liow JS; Cai L; Jacobowitz D; Musachio JL; Hong J; Crescenzo M; Tipre D; Lu JQ; Zoghbi S; Vines DC; Seidel J; Katada K; Green MV; Pike VW; Cohen RM; Innis RB
Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432
[TBL] [Abstract][Full Text] [Related]
9. Antibody-Based In Vivo PET Imaging Detects Amyloid-β Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition.
Meier SR; Syvänen S; Hultqvist G; Fang XT; Roshanbin S; Lannfelt L; Neumann U; Sehlin D
J Nucl Med; 2018 Dec; 59(12):1885-1891. PubMed ID: 29853653
[TBL] [Abstract][Full Text] [Related]
10. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.
Rodriguez-Vieitez E; Ni R; Gulyás B; Tóth M; Häggkvist J; Halldin C; Voytenko L; Marutle A; Nordberg A
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1119-32. PubMed ID: 25893384
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal evaluation of a novel BChE PET tracer as an early
Rejc L; Gómez-Vallejo V; Joya A; Moreno O; Egimendia A; Castellnou P; Ríos-Anglada X; Cossío U; Baz Z; Passannante R; Tobalina-Larrea I; Ramos-Cabrer P; Giralt A; Sastre M; Capetillo-Zarate E; Košak U; Knez D; Gobec S; Marder M; Martin A; Llop J
Theranostics; 2021; 11(13):6542-6559. PubMed ID: 33995675
[No Abstract] [Full Text] [Related]
12. Evaluation of
Bandara N; Sharma AK; Krieger S; Schultz JW; Han BH; Rogers BE; Mirica LM
J Am Chem Soc; 2017 Sep; 139(36):12550-12558. PubMed ID: 28823165
[TBL] [Abstract][Full Text] [Related]
13. Design of a multivalent bifunctional chelator for diagnostic
Cho HJ; Huynh TT; Rogers BE; Mirica LM
Proc Natl Acad Sci U S A; 2020 Dec; 117(49):30928-30933. PubMed ID: 33234563
[TBL] [Abstract][Full Text] [Related]
14. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET.
Rominger A; Brendel M; Burgold S; Keppler K; Baumann K; Xiong G; Mille E; Gildehaus FJ; Carlsen J; Schlichtiger J; Niedermoser S; Wängler B; Cumming P; Steiner H; Herms J; Haass C; Bartenstein P
J Nucl Med; 2013 Jul; 54(7):1127-34. PubMed ID: 23729696
[TBL] [Abstract][Full Text] [Related]
16. Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer's Disease Model Mice.
Shukuri M; Mawatari A; Ohno M; Suzuki M; Doi H; Watanabe Y; Onoe H
J Nucl Med; 2016 Feb; 57(2):291-6. PubMed ID: 26585055
[TBL] [Abstract][Full Text] [Related]
17. Imaging copper metabolism imbalance in Atp7b (-/-) knockout mouse model of Wilson's disease with PET-CT and orally administered 64CuCl2.
Peng F; Lutsenko S; Sun X; Muzik O
Mol Imaging Biol; 2012 Oct; 14(5):600-7. PubMed ID: 22170165
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.
Valtorta S; Belloli S; Sanvito F; Masiello V; Di Grigoli G; Monterisi C; Fazio F; Picchio M; Moresco RM
J Nucl Med; 2013 Jul; 54(7):1106-12. PubMed ID: 23699667
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model.
Waldron AM; Wyffels L; Verhaeghe J; Richardson JC; Schmidt M; Stroobants S; Langlois X; Staelens S
J Alzheimers Dis; 2017; 55(4):1537-1548. PubMed ID: 27911309
[TBL] [Abstract][Full Text] [Related]
20. Quantitative μPET Imaging of Cerebral Glucose Metabolism and Amyloidosis in the TASTPM Double Transgenic Mouse Model of Alzheimer's Disease.
Waldron AM; Wyffels L; Verhaeghe J; Bottelbergs A; Richardson J; Kelley J; Schmidt M; Stroobants S; Langlois X; Staelens S
Curr Alzheimer Res; 2015; 12(7):694-703. PubMed ID: 26159204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
